Mark Noviski

6PUBLICATIONS
73CO-AUTHORS
Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 01, 2024
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127.

Skye Montoya, Jessie Bourcier, Mark Noviski

|Sep 02, 2020
NR4A nuclear receptors restrain B cell responses to antigen when second signals are absent or limiting.

Corey Tan, Ryosuke Hiwa, James L Mueller

|Oct 22, 2019
Self-reactivity on a spectrum: A sliding scale of peripheral B cell tolerance.

Corey Tan, Mark Noviski, John Huizar

|Mar 10, 2018
IgM and IgD B cell receptors differentially respond to endogenous antigens and control B cell fate.

Mark Noviski, James L Mueller, Anne Satterthwaite

Pageof 1